In this paper we have proven uniqueness theorems for estimation of the age-dependent parameter α in the Gompertz survival model with a mortality deceleration rate, in the absence of age-specific mortality data. We obtained estimations dependent on and uniform in the population size N .
Introduction
Senescence is a gradual deterioration of physiological function with increasing age and is generally associated with decreasing performance, decreasing fecundity or an increasing probability of mortality with increasing age [1] . In humans and many other organisms the mortality rate m(t) increases approximately exponentially with age [2] . Gompertz [3] was the first to recognize this dependency of mortality rate on chronological age and expressed it mathematically by the equation
where m(t) is the mortality rate at time t, the positive parameter A is the age-independent mortality rate or the initial mortality rate (IMR) and the positive parameter α is the age-dependent mortality rate. This model has the nice property that ln[|m(t)|] = ln(|A|) + αt describes a straight line. Differences in mortality rates among organisms, whether different species or groups exposed to different experimental treatments within a species, can be compared by simply comparing the parameters of the Gompertz model, in which a higher α implies a more rapid increase in the mortality rate with age and a higher A indicates a higher intercept. The exact shape of the function describing mortality rates in humans has implications for predictions of demography trends [4] .
The corresponding survival function can be obtained by integrating the mortality rate (m(t)) given in Eq. (1):
The two parameters A and α are of interest to many investigators in biogerontology and the evolutionary biology of aging [5] [6] [7] [8] . Species comparisons in mortality rates are aided by calculations of MRD (mortality rate decrement) which changes in the same direction as lifespan and is given by
Usually, an experimentalist knows the individual's lifespan and can make use of standard techniques such as M L E or linear regression [9, 10] to estimate the model parameters.
A problem arises when, for some reason, the lifespans are not known exactly or not known at all. Under these conditions, it becomes much more difficult to estimate the two model parameters. Witten and Satzer [11] introduced a procedure for obtaining an estimate of α if A and a finite maximum lifespan can be assumed in such cases; and Lakshminarayanan and Pitchaimani [7, 12] obtained the unique solution and the asymptotic formulae of A and α for cases where the individual lifespans of those in the initial population are unavailable.
Estimation of parameters
Senescence is generally quantified as an increase in the mortality rate with increasing age. The rate of senescence, measured as the exponent (α) describing the exponential rate of increase in mortality rate (m(t)) with increasing age, has until recently been believed to vary little within species (Finch, [2] ). However, recent studies have shown that patterns of increase in mortality rates vary among populations or among cohorts/genotypes within populations of a species [1] [2] [3] [4] . For senescence to evolve in response to natural selection, there must be genetic variation in the shape of the mortality curve in the age range where fertility or reproductive capacity is present. However, few studies have examined the degree to which mortality curves vary in shape, and even fewer have demonstrated that mortality curves are genetically variable or have examined which features of the curves are genetically variable [4] .
It is well known that among most mammals, mortality rates are generally lowest at puberty and then accelerate at a constant rate during the major phase of adult life. When examined from puberty onwards, the mortality rate during adult aging fits the Gompertz model, at least up through the average lifespan [2] . However extensive deviations from the Gompertz model were recently documented, in which the mortality rate slows markedly by the average lifespan, e.g., in laboratory populations of fruit flies [13] . In human populations, according to published studies [14] , the acceleration of mortality rate slows after 85 years. After 105 years, the mortality rate appears to cease increasing and may even decrease at these extremely advanced ages. Current evidence indicates that human mortality rates at ages above 85 are less than those predicted by the Gompertz law. In extreme old age, mortality rate may level off or even decline [15] .
Carey, Liedo, Orozco and Vaupel (CLOV) [13] performed a series of experiments on Mediterranean fruit flies (med flies). They found that in all specimens under different conditions the Gompertz law broke down at higher ages, indicating that the law is only an approximate expression. A report of CLOV experiments [16] also suggests that at higher ages beyond 80 days (med flies), the mortality rate m(t) tends to fluctuate; it rises first
There is additional evidence for the exponential decay at higher ages. Quite recently Wang and co-workers [17] disclosed an elegant experiment for the senescence accelerated mouse (SAM), showing that the mouse mortality rate also approaches a constant value at higher age.
All the evidence accumulated so far suggests strongly that the exponential decay of populations at higher age is a general phenomenon [16] . Note that not all populations show mortality deceleration at higher ages (see Finch et al. [18] ).
In such cases, the Gompertz equation (1) is a poor description of mortality dynamics. To correct for departures from Gompertz, the logistic frailty model was also examined:
(Vaupel [19] ). Early in life (t near zero), mortality increases exponentially at a rate determined by A and α. The parameter s determines the extent to which mortality rates decelerate late in life. Higher values of s indicate greater deceleration. Note that when s = 0, Eq. (4) reduces to Eq. (1). A general measure of the rate of senescence is the acceleration of mortality rate, represented here by the time required for the mortality rate to double (MRD). Rhesus monkeys can have MRD close to that of humans, about 8 years; their shorter lifespan results mainly from higher mortality at all ages. In contrast, some groups with short lifespans (rodents and galliform birds) have shorter MRDs, and faster senescence [20] . With the Gompertz model MRD depends only on α, as seen in Eq. (3). Solving Eq. (4) for MRD gives
(Note that when s = 0, Eq. (5) reduces to Eq. (3)). Species comparisons in mortality rate accelerations are aided by calculations of the MRD, because MRD changes in the same direction as lifespan. Despite major differences in overall mortality rates among diverse human populations, MRDs are stable at 7-8.5 years, about 30 fold longer than in laboratory rodents [8] . Comparison of different adult human populations shows parallel curves in plots of the natural logarithm of mortality rate m(t) as a function of age, which implies that MRD is stable whether it be under lifelong adverse or favorable conditions. Moreover, MRD is also remarkably stable during briefer adversity.
The corresponding survival function can be obtained by integrating the mortality rate equation (4);
It is difficult, in general, to decide upon a particular value of t to use in Eq. (6). However if we are examining the issue of evolution of longevity, then choosing t = t max , the known maximum lifespan, is a reasonable starting value. Finally for ease of analysis we may set S(t m ) = 1 N (the population contains only one individual left from an original population size N ). We obtain the following equation for t m (the time at which the population has only one individual and which approximates the maximum lifespan t * m )
The average mortality rate of a steady-state population subject to the age-specific mortality rate of Eq. (4) is [7] A av = 1
Eq. (7) gives
and substituting the value of S(t) (Eq. (6)) into Eq. (8), we get
A simple substitution in the integral gives
(where z ≡ s A α e αt (= N s −1 e αtm −1 e αt )). In the presence of mortality data by age, the Gompertz parameters A and α have been estimated by using various statistical methods like maximum likelihood, linear regression, nonlinear regression, etc.
In the absence of age specific mortality data, C.E. Finch et al. [8] have developed a method to estimate initial mortality rate and mortality rate to double (MRD) from the average adult mortality rate (A av ) and maximum lifespan (t m ).
The basic equation (10) is transcendental, involving an exponential function, and hence its solution may not be unique. It is thus necessary to investigate the uniqueness of the solution of (10).
Uniqueness
Before proving the uniqueness theorems, we observe that the product of the age-independent parameter with the mortality deceleration rate cannot exceed the average mortality rate A av , because the latter represents contributions from s A and α.
Here is the proof: 
Thus, the product of the initial mortality rate with mortality deceleration rate cannot exceed min( Proof. Suppose α 1 and α 2 are two solutions of Eq. (10), i.e.
where
Therefore, 
Applying the mean value theorem, we get
Since 2A av t m < 1, the last inequality implies that α 1 ≡ α 2 . We note that the uniqueness condition 2A av t m < 1 is independent of population size N . It is interesting to compare the uniqueness condition with the given mortality estimation, using a linear regression model [8] , in Table 1 . 
A necessary condition for uniqueness
we get
.
Hence, Table 2 Illustrative logistic frailty model parameters for populations of legume species. MRD is calculated (Eq. (5)) from the age-related mortality coefficient, α, A and s. t m is calculated from reported α, A and s for population of different sizes N . The source of data for each species is given in [22] A Thus,
Suppose we have a unique solution of (10). It follows from (12) that
Since 0 < x e x −1 ≤ 1, ∀x ≥ 0, from (13), we get 
Note that max( In the following discussion, we will examine parameter sensitivity in the above model formulations.
Sensitivity to parameter changes
From the work of Witten and Satzer [11] we know that in the standard Gompertz mortality model the age-dependent mortality rate α becomes insensitive to changes in the initial population size N if N approaches a very large value, but becomes very sensitive to changes in N if N approaches 1. Similarly we would now like to consider how an analogous system that includes a deceleration parameter, as represented by Eq. (10), behaves when N , A av , t m and s are large. To do this, we consider the partial derivatives of α with respect to N , A av , t m and s. These are given by 
At m e αtm
respectively. Considering the R.H.S. in (14) ,
At m e αtm N s −1 + A av t m e αtm e αtm −1 − 1 and using (9), we can express it as
Since s A ≤ A av , and A ≤ A av [7] , there is the implication that s ∈ (0,
x , ∀x ≥ 0 and s ∈ (0, A av A ], the denominator of the R.H.S of (14) given in the expression (18) has the property
Hence, because the numerator of the expression (18) contains only positive terms it follows that
Comparing the expressions and relationships given in (14) , (18) and (19) In view of this, we get Thus, we see that α is relatively insensitive to changes in N . That is, α does not change rapidly as the sample size becomes larger. Finally, if we let N approach 1 in (15)- (17) Thus, as the population size decreases, we see a greater change in the sensitivity of α.
Remark 1. From Theorem 2, it follows that, to have a unique age-independent parameter A, it is necessary that s A ≤ A av , since Remark 2. Note that the illustrative numerical solutions for logistic frailty model parameters given in Table 1 [21], (4) and (6) reduce to Eqs. (1) and (2) respectively. This reveals that to have a unique age-dependent parameter α, it is necessary that A av t m ln N < 1 [7] .
Closing comments
The purpose of this discussion has been to address the issue of parameter sensitivity of a new method for estimating the age-dependent mortality rate α of the Gompertz mortality rate model with deceleration rate (or logistic frailty model). Such a method is necessary when attempting to estimate Gompertz mortality rate coefficients in the absence of mortality data by age.
